信息搜索
信息关键字:医药
 

共有1868条记录

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94]

·【医药】祝嘉琦:生长激素、血制品集采方案落地积极把握医药舒适窗口期2022-1-24 1:29:25
·医药行业周报:疫情主题资产博弈2022-1-23 12:21:01
·一边规模破千亿一边亏损上热搜“医药女神”葛兰四只产品过去一年告负为何越跌越买2022-1-23 12:00:02
·从数据看北向资金一周操作:军工、医药越跌越买,心头好仍然是价值大蓝筹2022-1-23 10:31:05
·主流赛道龙头陆续腰斩!医药赛道成最大输家,2022年初成长赛道如何走?2022-1-23 10:26:45
·主力机构蜂拥进场62亿资金狂买指数ETF医疗、医药份额再创历史新高!但火爆的酒、证券却被抛售2022-1-22 15:36:45
·沃华医药2021年净利润1.63亿同比减少8.7%董秘赵彩霞薪酬86.64万元2022-1-22 12:22:55
·人福医药2名股东合计增持100.9万股耗资2074.46万2021年第三季度公司净利4.32亿2022-1-22 3:03:19
·多瑞医药:为进一步优化股权投资结构拟收购控股子公司嘉诺康剩余20%股权2022-1-22 0:08:33
·复星医药获MPP新冠口服药生产许可对收入等影响尚无法预计2022-1-21 22:27:44
·医药圈怎么了?默沙东新冠口服药授权国内仿制,中选药企立马大涨,板块却绿了一片!2022-1-21 21:32:37
·长春高新跌停三连板仿新冠口服药获许可助推博瑞医药、复星医药大涨「制药行业周榜」2022-1-21 20:12:51
·复星医药:获许可区域为印度、巴基斯坦、科特迪瓦等105个中低收入国家/地区不包括中国2022-1-21 20:08:30
·A股资金面日报:148亿主力资金撤离医药生物行业北向资金抢筹五粮液2022-1-21 20:04:34
·复盘61涨停股:九安医疗跌停金财互联7板复星医药炸板2022-1-21 17:49:33
·跌上微博热搜,医药基金女神栽了,“东北药茅”遭滑铁卢,“妖王之王”跌停,股神巴菲特新动向曝光!2022-1-21 16:50:06
·医药股几家欢喜几家愁!长春高新连“吃”三跌停博瑞医药竟然一字涨停发生了什么?2022-1-21 14:03:53
·连续四季度折戟老将邬传雁袒露反思心声罕见建仓“互联网大厂”继续坚守“医药茅”2022-1-21 10:36:19
·复星医药、博瑞医药双双涨停开盘2022-1-21 9:41:48
·70余家医药公司预告业绩八成实现利润增长2022-1-21 5:13:57

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94]